Engineers Gate Manager’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.05M | Sell |
69,390
-148,910
| -68% | -$2.25M | 0.01% | 1048 |
|
|
2026
Q1 | $2.38M | Sell |
218,300
-73,032
| -25% | -$912K | 0.03% | 654 |
|
|
2025
Q4 | $3.77M | Buy |
291,332
+18,006
| +7% | +$231K | 0.04% | 423 |
|
|
2025
Q3 | $3.53M | Sell |
273,326
-20,224
| -7% | -$270K | 0.04% | 513 |
|
|
2025
Q2 | $5.23M | Buy |
293,550
+39,511
| +16% | +$689K | 0.07% | 377 |
|
|
2025
Q1 | $4.53M | Buy |
254,039
+55,106
| +28% | +$1.25M | 0.08% | 365 |
|
|
2024
Q4 | $5.93M | Sell |
198,933
-103,796
| -34% | -$2.2M | 0.1% | 278 |
|
|
2024
Q3 | $4.73M | Buy |
302,729
+9,866
| +3% | +$179K | 0.09% | 308 |
|
|
2024
Q2 | $5.02M | Buy |
292,863
+10,026
| +4% | +$176K | 0.11% | 263 |
|
|
2024
Q1 | $4.42M | Sell |
282,837
-49,933
| -15% | -$734K | 0.12% | 227 |
|
|
2023
Q4 | $4.97M | Buy |
332,770
+155,982
| +88% | +$2.09M | 0.14% | 185 |
|
|
2023
Q3 | $2.86M | Buy |
176,788
+110,417
| +166% | +$3.18M | 0.11% | 256 |
|
|
2023
Q2 | $2.75M | Buy |
66,371
+31,543
| +91% | +$1.96M | 0.1% | 243 |
|
|
2023
Q1 | $2.09M | Buy |
+34,828
| New | +$2.78M | 0.09% | 305 |
|
|
2022
Q3 | – | Sell |
-15,512
| Closed | -$1.08M | – | 1936 |
|
|
2022
Q2 | $1.08M | Buy |
15,512
+3,204
| +26% | +$241K | 0.04% | 666 |
|
|
2022
Q1 | $1.02M | Sell |
12,308
-62,002
| -83% | -$4.57M | 0.04% | 669 |
|
|
2021
Q4 | $5.58M | Buy |
74,310
+54,415
| +274% | +$5.46M | 0.25% | 59 |
|
|
2021
Q3 | $2.31M | Buy |
19,895
+18,016
| +959% | +$2.72M | 0.13% | 192 |
|
|
2021
Q2 | $417K | Sell |
1,879
-4,582
| -71% | -$891K | 0.03% | 939 |
|
|
2021
Q1 | $854K | Sell |
6,461
-6,376
| -50% | -$1.01M | 0.04% | 659 |
|
|
2020
Q4 | $2.22M | Sell |
12,837
-16,937
| -57% | -$2.32M | 0.1% | 301 |
|
|
2020
Q3 | $3.31M | Buy |
29,774
+10,404
| +54% | +$832K | 0.16% | 152 |
|
|
2020
Q2 | $1.15M | Sell |
19,370
-37,708
| -66% | -$2.48M | 0.06% | 538 |
|
|
2020
Q1 | $3.84M | Buy |
57,078
+46,359
| +432% | +$3.66M | 0.28% | 59 |
|
|
2019
Q4 | $903K | Buy |
10,719
+5,341
| +99% | +$431K | 0.04% | 697 |
|
|
2019
Q3 | $402K | Sell |
5,378
-58,127
| -92% | -$4.65M | 0.02% | 880 |
|
|
2019
Q2 | $4.01M | Sell |
63,505
-22,161
| -26% | -$1.12M | 0.22% | 125 |
|
|
2019
Q1 | $4.13M | Buy |
+85,666
| New | +$4.12M | 0.25% | 120 |
|
|
2018
Q4 | – | Sell |
-5,371
| Closed | -$281K | – | 1054 |
|
|
2018
Q3 | $281K | Sell |
5,371
-54,849
| -91% | -$2.18M | 0.02% | 664 |
|
|
2018
Q2 | $1.89M | Buy |
+60,220
| New | +$1.68M | 0.15% | 229 |
|
|
2018
Q1 | – | Sell |
-67,899
| Closed | -$1.37M | – | 922 |
|
|
2017
Q4 | $1.37M | Buy |
67,899
+45,438
| +202% | +$875K | 0.09% | 394 |
|
|
2017
Q3 | $446K | Sell |
22,461
-65,182
| -74% | -$1.28M | 0.04% | 572 |
|
|
2017
Q2 | $1.52M | Buy |
+87,643
| New | +$1.13M | 0.14% | 279 |
|
Other funds holding NVCR
SCM
QCM
Engineers Gate Manager's NVCR Position: Q2 2026 in Review
Engineers Gate Manager reduced its NovoCure (NVCR) stake by 68% in Q2 2026, selling an estimated $2.25M and leaving 69,390 shares worth $1.05M. The position accounts for 0.01% of the portfolio, ranked #1048.
Engineers Gate Manager first reported a position in NVCR in Q2 2017 and has held it in 33 quarters since. The position peaked at $5.93M in Q4 2024. 216 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.
- Engineers Gate Manager held 69,390 shares of NovoCure worth $1.05M as of Q2 2026.
- Engineers Gate Manager sold 148,910 NovoCure shares in Q2 2026, an estimated $2.25M.
- NovoCure made up 0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #1048 holding.
- Engineers Gate Manager first reported a position in NovoCure in Q2 2017 and has held it in 33 quarters since.
- Engineers Gate Manager's NovoCure position peaked at $5.93M in Q4 2024.
- 216 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.
Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.